Sudarshan Chemical Industries quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	2,642	2,507	+5.4%
EBITDA	259	192	+34.5%
EBITDA margin	9.8%	7.7%	+2.1 pts
Profit before tax	144	75.1	+92.0%
Net profit	103	55.0	+88.0%
EPS	₹12.30	₹6.00	+105.0%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	2,642	2,790	2,103	2,387	2,507	1,349	666	696	634	764	566	601	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	19.0	10.4	14.2	28.8	25.8	20.4	4.5	5.0	3.5	3.0	4.3	5.7
	2,661	2,800	2,117	2,416	2,533	1,370	671	701	637	767	570	606
	1,362	1,183	979	1,219	1,376	2,165	347	436	369	399	303	334
	71.2	45.4	0.0	0.0	0.0	0.0	3.9	8.9	5.1	2.7	4.4	4.7
	−209	249	102	−28.3	−153	−1,473	20.8	−75.8	−34.1	34.3	5.2	−6.0
	440	422	395	416	434	189	55.8	56.8	54.4	52.5	53.6	52.6
	40.5	40.8	36.4	43.6	44.1	21.0	11.4	8.9	7.0	8.4	8.6	9.6
	93.1	50.4	101	97.2	99.0	57.1	36.5	36.6	35.9	35.7	35.5	35.4
	718	664	588	649	658	341	160	176	158	156	138	150
	2,517	2,654	2,202	2,396	2,458	1,301	635	647	596	689	548	580
	259	227	37.9	132	192	127	79.0	94.5	80.6	119	61.9	65.6
	166	177	−62.7	35.0	93.4	69.8	42.4	57.9	44.6	83.4	26.4	30.2
Profit
	144	147	−84.9	20.2	75.1	69.3	35.5	54.0	41.1	78.0	22.1	26.2
	0.0	15.7	−45.4	0.0	0.0	−61.6	−30.8	−11.2	0.0	0.0	0.0	0.0
	144	162	−130	20.2	75.1	7.7	4.7	42.8	41.1	78.0	22.1	26.2
	69.7	72.3	23.4	42.6	69.5	34.0	11.1	23.7	16.8	11.8	3.7	2.9
	−15.7	12.9	−30.2	−32.4	−42.3	−23.8	−6.9	−10.8	−5.1	8.2	3.8	5.5
	54.0	85.2	−6.8	10.2	27.2	10.3	4.2	12.9	11.7	20.0	7.5	8.4
	13.2	5.4	7.5	9.3	7.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0
	103	82.5	−116	19.3	55.0	0.3	0.5	29.9	29.4	58.0	14.6	17.9
	90.2	77.1	−124	10.0	47.9	−2.6	0.5	29.9	29.4	58.0	14.6	17.9
	12.1	67.3	−18.2	30.1	1.8	1,226	−0.5	4.1	5.9	0.8	−2.5	−3.0
	116	150	−134	49.4	56.8	1,226	−0.0	34.0	35.4	58.9	12.1	14.9
	97.3	78.7	−115	11.7	47.2	−4.1	0.5	29.9	29.4	58.0	14.6	17.9
	6.1	3.8	−0.7	7.6	7.8	4.4	0.0	0.0	0.0	0.0	0.0	0.0
Per share
	₹12.30	₹10.00	−₹14.70	₹1.50	₹6.00	₹7.60	₹0.10	₹4.30	₹4.30	₹8.40	₹2.10	₹2.60
	₹12.30	₹10.00	−₹14.70	₹1.50	₹6.00	₹7.60	₹0.10	₹4.30	₹4.20	₹8.40	₹2.10	₹2.60
Other comprehensive income — detail
	12.1	67.3	−18.2	30.1	1.8	1,226	—	—	—	—	—	—
	−3.3	32.6	−0.4	−4.4	−0.5	6.0	−0.8	−1.1	0.9	−1.0	−0.8	−1.0
	−0.9	4.3	0.0	−0.6	0.0	0.7	—	—	—	—	—	—
	—	—	—	—	—	—	−0.2	−0.3	0.2	−0.2	−0.2	−0.3
	14.5	39.0	−18.0	33.8	2.3	1,220	0.0	4.3	4.9	1.1	−2.4	−2.7
	0.0	0.0	−0.2	−0.1	0.0	−0.7	—	—	—	—	—	—
	—	—	—	—	—	—	−0.1	−0.6	−0.3	−0.5	−0.4	−0.4
	109	146	−134	41.9	49.1	1,222	−0.0	34.0	35.4	58.9	12.1	14.9
	6.3	4.3	−0.4	7.5	7.7	4.2	0.0	0.0	0.0	0.0	0.0	0.0
Per share — as-filed variants
	₹12.30	₹10.00	−₹14.70	₹1.50	₹6.00	₹7.60	₹0.10	₹4.30	₹4.30	₹8.40	₹2.10	₹2.60
	₹12.30	₹10.00	−₹14.70	₹1.50	₹6.00	₹7.60	₹0.10	₹4.30	₹4.20	₹8.40	₹2.10	₹2.60
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	1,418	1,313	1,022	1,197	1,284	657	294	327	293	328	253	268
	53.7%	47.1%	48.6%	50.1%	51.2%	48.7%	44.2%	47.0%	46.3%	42.9%	44.8%	44.7%
Adjusted (ex-exceptional items) — derived
	144	147	−84.9	20.2	75.1	69.3	35.5	54.0	41.1	78.0	22.1	26.2
	0.0	15.7	−45.4	0.0	0.0	−61.6	−30.8	−11.2	0.0	0.0	0.0	0.0
	103	75.0	−73.0	19.3	55.0	25.0	12.8	37.7	29.4	58.0	14.6	17.9
	₹12.30	₹9.10	−₹9.25	₹1.50	₹6.00	₹606.30	₹2.50	₹5.42	₹4.30	₹8.40	₹2.10	₹2.60

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SUDARSCHEM₹1,081.00

Sudarshan Chemical Industries Ltd.

· Chemicals

Annual Quarterly₹ CrorePeersSUDEEPPHRM STYRENIX SHARDACROP REFEX RCF RALLIS RAIN PRIVISCLMcap ₹8,486 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	600.7	565.8	764.2	633.6	696.1	666.4	1,349.4	2,506.9	2,387.4	2,103.0	2,789.9	2,642.1
Other Income	5.7	4.3	3.0	3.5	5.0	4.5	20.4	25.8	28.8	14.2	10.4	19.0
Total Income	606.4	570.0	767.2	637.1	701.1	670.9	1,369.9	2,532.7	2,416.2	2,117.2	2,800.3	2,661.1
Expenses
+ Cost of Materials Consumed	333.5	302.8	399.2	369.3	435.8	347.3	2,165.3	1,375.8	1,219.1	979.3	1,182.8	1,362.1
+ Purchases of Stock-in-Trade	4.7	4.4	2.7	5.1	8.9	3.9	0.0	0.0	0.0	0.0	45.4	71.2
+ Changes in Inventories	-6.0	5.2	34.3	-34.1	-75.8	20.8	-1,472.9	-153.0	-28.3	102.2	248.5	-208.7
+ Employee Benefit Expense	52.6	53.6	52.5	54.4	56.8	55.8	189.1	433.6	415.7	395.3	421.7	440.3
+ Finance Costs	9.6	8.6	8.4	7.0	8.9	11.4	21.0	44.1	43.6	36.4	40.8	40.5
+ Depreciation & Amortisation	35.4	35.5	35.7	35.9	36.6	36.5	57.1	99.0	97.2	100.6	50.4	93.1
+ Other Expenses	150.2	137.9	156.5	158.4	175.9	159.6	340.9	658.1	648.7	588.3	664.1	718.4
Total Expenses	580.1	547.9	689.2	596.0	647.1	635.4	1,300.5	2,457.6	2,396.0	2,202.1	2,653.7	2,516.9
EBITDA	65.6	61.9	119.1	80.6	94.5	79.0	127.0	192.4	132.2	37.9	227.4	258.8
EBIT	30.2	26.4	83.4	44.6	57.9	42.4	69.8	93.4	35.0	-62.7	177.0	165.7
Profit
PBT before Exceptional Items	26.2	22.1	78.0	41.1	54.0	35.5	69.3	75.1	20.2	-84.9	146.6	144.2
+ Exceptional Items	0.0	0.0	0.0	0.0	-11.2	-30.8	-61.6	0.0	0.0	-45.4	15.7	0.0
Pretax Income	26.2	22.1	78.0	41.1	42.8	4.7	7.7	75.1	20.2	-130.3	162.3	144.2
+ Current Tax	2.9	3.7	11.8	16.8	23.7	11.1	34.0	69.5	42.6	23.4	72.3	69.7
+ Deferred Tax	5.5	3.8	8.2	-5.1	-10.8	-6.9	-23.8	-42.3	-32.4	-30.2	12.9	-15.7
Tax Expense	8.4	7.5	20.0	11.7	12.9	4.2	10.3	27.2	10.2	-6.8	85.2	54.0
+ Share of Associates & JVs	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.1	9.3	7.5	5.4	13.2
Net Income	17.9	14.6	58.0	29.4	29.9	0.5	0.3	55.0	19.3	-116.0	82.5	103.4
+ Net Income — Continuing Ops	17.9	14.6	58.0	29.4	29.9	0.5	-2.6	47.9	10.0	-123.5	77.1	90.2
+ Other Comprehensive Income	-3.0	-2.5	0.8	5.9	4.1	-0.5	1,225.6	1.8	30.1	-18.2	67.3	12.1
Total Comprehensive Income	14.9	12.1	58.9	35.4	34.0	-0.0	1,225.9	56.8	49.4	-134.2	149.8	115.5
Net Income to Common	17.9	14.6	58.0	29.4	29.9	0.5	-4.1	47.2	11.7	-115.3	78.7	97.3
Minority Interest	0.0	0.0	0.0	0.0	0.0	0.0	4.4	7.8	7.6	-0.7	3.8	6.1
Per Share
Basic EPS	2.60	2.10	8.40	4.30	4.30	0.10	7.60	6.00	1.50	-14.70	10.00	12.30
Diluted EPS	2.60	2.10	8.40	4.20	4.30	0.10	7.60	6.00	1.50	-14.70	10.00	12.30
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	1,225.6	1.8	30.1	-18.2	67.3	12.1
+ Items NOT to be Reclassified to P&L	-1.0	-0.8	-1.0	0.9	-1.1	-0.8	6.0	-0.5	-4.4	-0.4	32.6	-3.3
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.7	0.0	-0.6	0.0	4.3	-0.9
+ Tax on Items NOT to be Reclassified — alt tag	-0.3	-0.2	-0.2	0.2	-0.3	-0.2	—	—	—	—	—	—
+ Items to be Reclassified to P&L	-2.7	-2.4	1.1	4.9	4.3	0.0	1,219.6	2.3	33.8	-18.0	39.0	14.5
+ Tax on Items to be Reclassified	—	—	—	—	—	—	-0.7	0.0	-0.1	-0.2	0.0	0.0
+ Tax on Items to be Reclassified — alt tag	-0.4	-0.4	-0.5	-0.3	-0.6	-0.1	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	14.9	12.1	58.9	35.4	34.0	-0.0	1,221.7	49.1	41.9	-133.8	145.5	109.2
Comprehensive Income — Non-controlling Interests	0.0	0.0	0.0	0.0	0.0	0.0	4.2	7.7	7.5	-0.4	4.3	6.3
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.60	2.10	8.40	4.30	4.30	0.10	7.60	6.00	1.50	-14.70	10.00	12.30
Diluted EPS — Continuing Operations	2.60	2.10	8.40	4.20	4.30	0.10	7.60	6.00	1.50	-14.70	10.00	12.30
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	268.4	253.4	328.1	293.3	327.1	294.4	657.0	1,284.1	1,196.6	1,021.5	1,313.2	1,417.5
Gross Margin %	44.68	44.78	42.93	46.29	47.00	44.18	48.69	51.22	50.12	48.57	47.07	53.65
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	26.2	22.1	78.0	41.1	54.0	35.5	69.3	75.1	20.2	-84.9	146.6	144.2
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	-11.2	-30.8	-61.6	0.0	0.0	-45.4	15.7	0.0
Net Income Adj (tax-effected)	17.9	14.6	58.0	29.4	37.7	12.8	25.0	55.0	19.3	-73.0	75.0	103.4
EPS Adj	2.60	2.10	8.40	4.30	5.42	2.50	606.30	6.00	1.50	-9.25	9.10	12.30
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Filed Debt Equity	1.00	0.00	—	0.00	0.00	0.00	0.95	1.01	0.00	0.00	—	—
Filed Dscr	2.00	1.00	—	2.00	2.00	2.00	2.40	2.83	0.00	0.00	—	—
Filed Iscr	7.00	8.00	—	12.00	11.00	7.00	6.90	4.85	0.00	0.00	—	—
Paid Up Equity Capital	13.8	13.8	13.8	13.8	13.8	13.8	15.7	15.7	15.7	15.7	15.7	15.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Sudarshan Chemical Industries quarterly results

Sudarshan Chemical Industries (NSE: SUDARSCHEM) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit attributable to shareholders was ₹97.3 crore, up 106.1% from ₹47.2 crore in Q1 FY26 and up 23.6% from ₹78.7 crore in Q4 FY26. Revenue from operations was ₹2,642 crore, up 5.4% year on year and down 5.3% from the previous quarter.

Q2 FY26 results (a year earlier): 12 November 2025
Q1 FY27 results (the latest): 12 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹97.3 Cr+106.1% vs Q1 FY26+23.6% vs Q4 FY26
Q1 FY27 revenue: ₹2,642 Cr+5.4% vs Q1 FY26−5.3% vs Q4 FY26
Q1 FY27 operating margin: 6.3%+2.5 pts vs Q1 FY26−0.1 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹11.7 CrRevenue ₹2,387 Cr
Q1 FY27 EPS (basic): ₹12.30

Questions

When will Sudarshan Chemical Industries announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 12 November 2025.

What will Sudarshan Chemical Industries' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit attributable to shareholders was ₹11.7 crore and revenue from operations ₹2,387 crore. The latest quarter, Q1 FY27, had a net profit of ₹97.3 crore and revenue of ₹2,642 crore.

What was Sudarshan Chemical Industries' revenue in FY26?

Revenue from operations was ₹9,787 crore in FY26 (April 2025–March 2026), up 192.5% from ₹3,346 crore in FY25. It was ₹2,539 crore in FY24 and ₹2,302 crore in FY23: up 325.2% over three years, 62.0% a year on average.

What were Sudarshan Chemical Industries' Q1 FY27 results?

Consolidated net profit attributable to shareholders was ₹97.3 crore, up 106.1% from ₹47.2 crore in Q1 FY26 and up 23.6% from ₹78.7 crore in Q4 FY26. Revenue from operations was ₹2,642 crore, up 5.4% year on year and down 5.3% from the previous quarter.

How has Sudarshan Chemical Industries' profit changed over the last four quarters?

Net profit attributable to shareholders by quarter: a profit of ₹11.7 crore in Q2 FY26, a loss of ₹115 crore in Q3 FY26, a profit of ₹78.7 crore in Q4 FY26 and a profit of ₹97.3 crore in Q1 FY27. That is a combined profit of ₹72.4 crore over the four quarters, down 1.5% from ₹73.5 crore in the four quarters before. Revenue from operations: ₹2,387 crore, ₹2,103 crore, ₹2,790 crore and ₹2,642 crore.

What was Sudarshan Chemical Industries' net profit in FY26?

Consolidated net profit attributable to shareholders was ₹22.3 crore in FY26 (April 2025–March 2026), down 60.0% from ₹55.8 crore in FY25. It was ₹357 crore in FY24 and ₹44.8 crore in FY23: down 50.2% over three years, an average fall of 20.7% a year.

Where do these Sudarshan Chemical Industries figures come from?

From Sudarshan Chemical Industries' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.